会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination
    • 生产具有降低复制水平的腺病毒载体的腺病毒载体
    • US07189561B2
    • 2007-03-13
    • US10946484
    • 2004-09-21
    • Frank L. Graham
    • Frank L. Graham
    • C12N15/34C12N15/64C12N15/63C12N5/10C12N15/861C07H21/04
    • C12N15/86C12N2710/10343C12N2800/30C12N2830/42C12N2840/20
    • Methods, cells and recombinant adenoviral vectors are disclosed that permit the production of recombinant adenoviral vector stocks with reduced levels of contamination by replication competent adenoviruses (RCA). In certain embodiments are disclosed early region 1 (E1) deficient recombinant adenoviral vectors and complementing E1 positive host cells whose sequences are designed to avoid formation of RCA by homologous recombination between sequences in the vector and E1 sequences in the cells. One aspect of the invention involves the inversion of the packaging signal in a recombinant adenoviral vector relative to an adjacent or nearby inverted terminal repeat (ITR). Methods include use of site-specific intregrase family recombinases such as Cre or FLP and recombinase recognition sites such as lox sites or frt sites.
    • 公开了方法,细胞和重组腺病毒载体,其允许通过复制性腺病毒(RCA)产生具有降低的污染水平的重组腺病毒载体原种。 在某些实施方案中公开了早期区域1(E1)缺陷型重组腺病毒载体和补体E1阳性宿主细胞,其序列被设计为避免通过载体中的序列和细胞中的E1序列之间的同源重组而形成RCA。 本发明的一个方面涉及重组腺病毒载体中相对于邻近或邻近倒置末端重复(ITR)的包装信号的反转。 方法包括使用位点特异性整合酶家族重组酶,如Cre或FLP以及重组酶识别位点,如lox位点或frt位点。